Pk Antigen

General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference

5 reference for EP0045

sort by year ∧ ∨ Reference detail
1 Naiki M, Marcus DM.
An immunochemical study of the human blood group P1, P, and PK glycosphingolipid antigens.
Biochemistry. 1975 Nov 4;14(22):4837-41
PMID: 1182122
2 Cooling LL, Walker KE, Gille T, Koerner TA.
Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
Infect Immun. 1998 Sep ;66(9):4355-66
PMID: 9712788
3 Oosterwijk E, Kalisiak A, Wakka JC, Scheinberg DA, Old LJ.
Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors.
Int J Cancer. 1991 Jul 30;48(6):848-54
PMID: 1860732
4 Okuda T, Tokuda N, Numata S, Ito M, Ohta M, Kawamura K, Wiels J, Urano T, Tajima O, Furukawa K, Furukawa K.
Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins.
J Biol Chem. 2006 Apr 14;281(15):10230-5
PMID: 16476743
5 Kojima Y, Fukumoto S, Furukawa K, Okajima T, Wiels J, Yokoyama K, Suzuki Y, Urano T, Ohta M, Furukawa K.
Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids.
J Biol Chem. 2000 May 19;275(20):15152-6
PMID: 10748143